Showing results (151-160 of 6,999) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|May 31, 2021
Lymph Node Dissection in Thymoma: Is it worth it?Hugo Clermidy, Jean-Michel Maury, Stéphane Collaud, et al.
Lung Cancer (Amsterdam, Netherlands)|October 30, 2020
Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective studyJiang-Tao Cheng, Yi-Hui Yao, Yu-Er Gao, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
PD-L1 expression in neuroendocrine tumors of the lungKenjiro Tsuruoka, Hidehito Horinouchi, Yasushi Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung diseaseNobuhiro Kanaji, Kenichiro Sakai, Yutaka Ueda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Improved survival with postoperative radiotherapy in thymic carcinoma: A propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) databaseYu Jin Lim, Changhoon Song, Jae-Sung Kim
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodulesYinan Liu, Hui Sun, Fei Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancerThomas Wehler, Michael Thomas, Christian Schumann, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapyMatthew Koshy, Renuka Malik, Michael Spiotto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Treatment options for EGFR mutant NSCLC with CNS involvement-Can patients BLOOM with the use of next generation EGFR TKIs?Chee-Seng Tan, Byoung Chul Cho, Ross A Soo
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Quantification of growth patterns of screen-detected lung cancers: The NELSON studyMarjolein A Heuvelmans, Rozemarijn Vliegenthart, Harry J de Koning, et al.
Pageof 700